Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134933) titled 'Evaluation of the efficacy and safety of papaverine in reducing myocardial injury during percutaneous coronary intervention in patients with myocardial infarction: a multicenter, randomized, double-blind, controlled clinical trial' on Oct. 22.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Qilu Hospital of Shandong University
Condition:
Acute myocardial infarction: Clinical manifestations, electrocardiogram results, and cardiac injury markers such as cTnI/T and CK-MB are used to diagnose acute myocardial infarction.
Intervention:
Intervention group:In addition to the standard phar...